Clinical Trials List
2024-12-30 - 2031-06-30
Phase II
Recruiting4
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ming-Ju Wu Division of Nephrology
- 邱顯富 Division of Nephrology
- 黃士婷 Division of Nephrology
- 許永楨 Division of Others
- Chia-Yen Lin Division of Urology
- TUNG-MIN YU Division of Nephrology
- 鍾牧圻 Division of Nephrology
- 吳致瑩 Division of Others
- Kuan-Der Lee Division of General Internal Medicine
- Cheng-Che Chen Division of Urology
- Cheng-Kuang Yang Division of Urology
- Jian-Ri Li Division of Urology
- 蔡尚峰 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- MENG-KUN TSAI Division of General Surgery
- 林維洲 Division of Others
- 陳建嘉 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳欣旭 Division of Nephrology
- Ya-Chung Tian Division of Nephrology
- Kun-Hua Tu Division of Nephrology
- 余美靜 Division of Pediatrics
- 王敘涵 Division of Urology
- 陳泰迪 Division of Others
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Sin-Syue Li Division of Hematology & Oncology
- 陳盈妊 Division of Others
- 黃絜歆 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
34 participants
